Ara
Toplam kayıt 47, listelenen: 21-30
Relation between olfactory dysfunction and episodic verbal memory in early Parkinson's disease
(Turkish Neuropsychiatric Society, 2014)
Introduction: Olfactory dysfunction is an early and common symptom in idiopathic Parkinson's disease (IPD). Recently, the relation between olfactory dysfunction and cognitive loss in IPD has been reported. In our study, ...
Parkinson's disease and the COVID-19 pandemic: Do quarantine affect the motor and non-motor symptoms of patients with and without deep brain stimulation?
(Galenos Publishing, 2022)
Aim: Patients with chronic diseases were forced into lockdown due to the coronavirus disease-2019 pandemic. Extended quarantine could lead to physical inactivity and psychiatric problems. We investigated the effects of ...
Virtual reality training helpful in motor and cognition in corticobasal syndrome: A case report PET study
(Karger, 2020)
Corticobasal syndrome (CBS) is a rare progressive neurodegenerative disease characterized by a combination of asymmetric motor symptoms and non-motor symptoms. CBS is poorly responsive to levodopa. Non-pharmacological ...
Acute and post-acute neuromodulation induces stroke recovery by promoting survival signaling, neurogenesis, and pyramidal tract plasticity
(Frontiers Media Sa, 2019)
Repetitive transcranial magnetic stimulation (rTMS) has gained interest as a non-invasive treatment for stroke based on the data promoting its effects on functional recovery. However, the exact action mechanisms by which ...
The neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseases
(Bentham Science Publishers, 2015)
Neuropharmacological relation of religious belief supports the role of dopaminergic activation as the leading neurochemical feature. However, vesicular monoamine transporter-2 (VMAT-2) has been shown to be responsible for ...
Lower extremity tremor exacerbation due to rivastigmine administration for treatment of parkinson’s disease dementia
(2018)
Rivastigmine is one of the approved effective treatments for Parkinson's Disease Dementia (PDD). Increase of upper extremity resting tremor is a common adverse effect seen in patients administered rivastigmine and is usually ...
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
(Elsevier Inc., 2023)
Background: Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD), are associated with metabolic abnormalities. Integrative analysis of human clinical data and animal studies ...
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: A randomised, double-blinded, placebo-controlled phase-II trial
(BioMed Central Ltd, 2023)
Background: Alzheimer’s disease (AD) is associated with metabolic abnormalities linked to critical elements of neurodegeneration. We recently administered combined metabolic activators (CMA) to the AD rat model and observed ...
Parkinson hastalarında kognitif ve duyu işlemleme süreçlerinin incelenmesi
(Türkiye Klinikleri Sağlık Bilimleri Dergisi, 2021)
Amaç: Çalışmamızda, Parkinson hastalarının kognitif ve duyusal işlemleme süreçlerindeki değişimlerin incelenmesi ve bu 2 sürecin birbiriyle olan bağıntısının anlaşılması hedeflenmiştir. Gereç ve Yöntemler: Bezmiâlem Vakıf ...
Effects of single-task, dual-task and successive physical-cognitive training on fall risk and balance performance in older adults: A randomized trial
(2022)
Purpose: This study aimed to examine the effects of single-task, dual-task and successive physical-cognitive training on fall risk, balance, and gait performances in elderly.Methods: A total of 45 healthy older adults ...